Displaying 1 - 1 of 1
| Active Ingredient | CISPLATIN |
| Therapeutic Class | ANTINEOPLASTICS |
| Indications | Treatment of testicular, lung, cervical, bladder, head and neck, and ovarian cancer. |
| Caution | Alop ecia, bone-marrow suppression,extravasation, hyperuricaemia, hypomagnesaemia, myelosuppression, nephrotoxicity severe nausea, severe vomiting. |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | Cisplatin may cause fetal harm when administered to a pregnant woman but potenti More ... |
| Breast Feeding | Cisplatin is distributed into milk. Nursing should be discontinued to avoid the More ... |